One of pharma's most notorious gougers is going bankrupt, but 2019 is a banner year for shkreli-grade pharmaceutical price-hikes

Back in September 2016, Novum Pharma made headlines when it raised the price of Aloquin, a barely-effective acne cream from $240/tube to $10,000/tube, after acquiring the exclusive right to manufacture it. Read the rest